pharmaceutical investing Zosano Announces Publication of Positive Data on Qtrypta’s™ Potential as an Acute Treatment for Patients with Difficult-to-Treat Migraines
pharmaceutical investing Zosano Pharma Enters Into Capital Equipment Lease Agreement With Trinity Capital Investment
DehydraTECH-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2
